Velarion Records
Free. Unsubscribe any time.

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Dianthus Therapeutics, Inc. /DE/ filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 61 transactions and 878,559 shares. 19 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Dianthus Therapeutics, Inc. /DE/ 61

Adoption dates in Dianthus Therapeutics, Inc. /DE/ 9

Results prints in Dianthus Therapeutics, Inc. /DE/ 0

Trades before a print in Dianthus Therapeutics, Inc. /DE/ 0

Interval to Dianthus Therapeutics, Inc. /DE/’s next reported results date

How the interval and sources are counted →

Adoption dates Dianthus Therapeutics, Inc. /DE/ states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 11, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.